SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
Cuba fights to contain spread of mosquito-borne chikungunya virus - 2Blake Lively's sexual harassment claims against Justin Baldoni dismissed. Where the case stands now.
- 3Extremely Rare Snub-Nosed Monkey Was Just Born for the First Time Outside of Asia
- 4A red meat allergy from tick bites is spreading – and the lone star tick isn’t the only alpha-gal carrier to worry about
- 5EU delegation urges China to tighten export controls
- Artemis II astronauts make long-distance call to the space station as they head home from the moon
- EU delays signing of Mercosur free trade deal
- 5 Pizza Fixings That Characterize Your Character
- Study finds humans were making fire 400,000 years ago, far earlier than once thought
- When preventable infections turn deadly behind bars | The Excerpt
- Figure out How to Consolidate Cutting edge innovations in Senior's SUVs
- Fuel Price Spike Drives Surge in Used EV Sales in Europe
- Shelby County deputies charged with assault, placed on leave
- One third of Spanish pork export certificates blocked since swine fever outbreak, minister says
